Rights and permissions
About this article
Cite this article
NZ’s PHARMAC to fund montelukast and ivermectin. Pharmacoecon. Outcomes News 660, 10 (2012). https://doi.org/10.2165/00151234-201206600-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206600-00030